» Articles » PMID: 30027669

Clinical and Genetic Ancestry Profile of a Large Multi-centre Sickle Cell Disease Cohort in Brazil

Abstract

Approximately 3500 children with sickle cell disease (SCD) are born in Brazil each year, but the burden of SCD morbidity is not fully characterised. A large, multi-centre cohort was established to characterise clinical outcomes in the Brazilian SCD population and create the infrastructure to perform genotype-phenotype association studies. Eligible patients were randomly selected from participating sites and recruited at routine visits. A biorepository of blood samples was created and comprehensive demographic and clinical outcome data were entered in a centralized electronic database. Peripheral blood genome-wide single nucleotide polymorphism (SNP) genotyping was performed using a customized Transfusion Medicine (TM) Array. A total of 2795 participants at six Brazilian sites were enrolled between 2013 and 2015. The cohort included slight predominance of children <18 years (55·9%) and females (53·0%). Haemoglobin (Hb) SS was the most common SCD genotype (70·7%), followed by HbSC (23%), Sβ0 (3·0%) and Sβ+ (2·9%). SNP data from the TM Array were analysed to evaluate the genetic ancestry of the cohort and revealed significant admixture among the population. Demographics and clinical complications, stratified by age and SCD genotype, are summarized and future studies in this cohort are discussed.

Citing Articles

Genetic Polymorphisms Associated with Fetal Hemoglobin (HbF) Levels and F-Cell Numbers: A Systematic Review of Genome-Wide Association Studies.

Stephanou C, Menzel S, Philipsen S, Kountouris P Int J Mol Sci. 2024; 25(21).

PMID: 39518961 PMC: 11546522. DOI: 10.3390/ijms252111408.


Impact of genetic background as a risk factor for atherosclerotic cardiovascular disease: A protocol for a nationwide genetic case-control (CV-GENES) study in Brazil.

de Oliveira Junior H, de Menezes Neves P, Oliveira G, Moreira F, Pintao M, Rocha V PLoS One. 2024; 19(3):e0289439.

PMID: 38478535 PMC: 10936812. DOI: 10.1371/journal.pone.0289439.


Real-world evidence of the burden of sickle cell disease: a 5-year longitudinal study at a Brazilian reference center.

Barros G, Leal C, Leite L, Fujimoto D, Cancado R Hematol Transfus Cell Ther. 2024; 46(2):161-166.

PMID: 38307824 PMC: 11150506. DOI: 10.1016/j.htct.2023.10.001.


is a candidate gene in sickle cell disease-associated pulmonary hypertension and pulmonary arterial hypertension.

Prohaska C, Zhang X, Schwantes-An T, Stearman R, Hooker S, Kittles R Pulm Circ. 2023; 13(2):e12227.

PMID: 37101805 PMC: 10124178. DOI: 10.1002/pul2.12227.


Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study.

Rolim Belisario A, Simoes E Silva A, Moura I, Carneiro-Proietti A, Sabino E, Loureiro P Ann Hematol. 2023; 102(5):1019-1027.

PMID: 36884065 DOI: 10.1007/s00277-023-05150-4.


References
1.
Makani J, Cox S, Soka D, Komba A, Oruo J, Mwamtemi H . Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One. 2011; 6(2):e14699. PMC: 3040170. DOI: 10.1371/journal.pone.0014699. View

2.
Piel F, Steinberg M, Rees D . Sickle Cell Disease. N Engl J Med. 2017; 376(16):1561-1573. DOI: 10.1056/NEJMra1510865. View

3.
Kleinman S, Busch M, Murphy E, Shan H, Ness P, Glynn S . The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion. 2013; 54(3 Pt 2):942-55. PMC: 4383641. DOI: 10.1111/trf.12468. View

4.
Saraf S, Molokie R, Nouraie M, Sable C, Luchtman-Jones L, Ensing G . Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatr Respir Rev. 2013; 15(1):4-12. PMC: 3944316. DOI: 10.1016/j.prrv.2013.11.003. View

5.
Weatherall D . The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010; 115(22):4331-6. PMC: 2881491. DOI: 10.1182/blood-2010-01-251348. View